Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,638
Closed -$288K 717
2024
Q1
$288K Buy
9,638
+640
+7% +$18.8K 0.01% 542
2023
Q4
$286K Sell
8,998
-455
-5% -$14.3K 0.01% 512
2023
Q3
$333K Hold
9,453
0.02% 462
2023
Q2
$359K Sell
9,453
-25
-0.3% -$997 0.02% 451
2023
Q1
$358K Sell
9,478
-792
-8% -$30.4K 0.02% 395
2022
Q4
$435K Sell
10,270
-1,570
-13% -$64.7K 0.03% 365
2022
Q3
$380K Sell
11,840
-156
-1% -$5.48K 0.03% 381
2022
Q2
$390K Hold
11,996
0.03% 387
2022
Q1
$434K Buy
11,996
+310
+3% +$10.6K 0.03% 378
2021
Q4
$462K Sell
11,686
-159
-1% -$6.63K 0.03% 373
2021
Q3
$518K Hold
11,845
0.03% 339
2021
Q2
$484K Buy
11,845
+124
+1% +$4.79K 0.03% 347
2021
Q1
$385K Sell
11,721
-287
-2% -$10.8K 0.03% 374
2020
Q4
$488K Hold
12,008
0.04% 322
2020
Q3
$440K Sell
12,008
-293
-2% -$10.6K 0.04% 312
2020
Q2
$417K Hold
12,301
0.04% 319
2020
Q1
$261K Buy
12,301
+800
+7% +$17.8K 0.03% 353
2019
Q4
$257K Buy
11,501
+236
+2% +$5.15K 0.02% 414
2019
Q3
$228K Buy
+11,265
New +$222K 0.02% 422

Other funds holding GMAB

Argent Trust Co's GMAB Position: Q2 2024 in Review

Argent Trust Co sold out of Genmab (GMAB) in Q2 2024, closing a stake of 9,638 shares — an estimated $288K sold.

Argent Trust Co first reported a position in GMAB in Q3 2019 and held it in 19 quarters. The position peaked at $518K in Q3 2021. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Argent Trust Co reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Argent Trust Co sold 9,638 Genmab shares in Q2 2024, an estimated $288K.
  • Argent Trust Co first reported a position in Genmab in Q3 2019 and held it in 19 quarters.
  • Argent Trust Co's Genmab position peaked at $518K in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Argent Trust Co's 13F filing for Q2 2024, filed 12 Aug 2024.